ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Should therapeutic heparin be administered to acutely-ill hospitalized patients with COVID-19"
Episode Synopsis
CHEST June 2022, Volume 161, Issue 6
David Jimenez, MD, PhD, and Tobias Tritschler, MD, MSc, join CHEST Podcast Moderator, Gretchen Winter, MD, to discuss whether therapeutic heparin should be administered to acutely-ill hospitalized patients with COVID-19.
DOI: https://doi.org/10.1016/j.chest.2022.01.036
DOI: https://doi.org/10.1016/j.chest.2022.01.037
DOI: https://doi.org/10.1016/j.chest.2022.01.038
DOI: https://doi.org/10.1016/j.chest.2022.01.039
David Jimenez, MD, PhD, and Tobias Tritschler, MD, MSc, join CHEST Podcast Moderator, Gretchen Winter, MD, to discuss whether therapeutic heparin should be administered to acutely-ill hospitalized patients with COVID-19.
DOI: https://doi.org/10.1016/j.chest.2022.01.036
DOI: https://doi.org/10.1016/j.chest.2022.01.037
DOI: https://doi.org/10.1016/j.chest.2022.01.038
DOI: https://doi.org/10.1016/j.chest.2022.01.039
More episodes of the podcast CHEST Journal Podcasts
October 2025 CHEST Journal Editor Highlights
01/10/2025
Humanities: Making Anger Count (Episode 3)
11/09/2025
Impact of COVID-19 on Pulmonary Critical Care Fellows In-Training Exam Performance: A National Study
01/09/2025
August 2025 CHEST Journal Editor Highlights
01/08/2025
July 2025 CHEST Journal Editor Highlights
01/07/2025
In God we trust